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No Evidence of Cytomegalovirus DNA in Alopecia Areata
To the Editor:
The etiology of alopecia areata (AA) remains unclear. In the past,
micro-organisms (bacteria, viruses, fungi) have been proposed as
triggering factors. Recent studies suggest that cytomegalovirus (CMV)
infection may play a pathogenic role in a variety of autoimmune
diseases, including type I diabetes mellitus, thyroid disease, and
rheumatoid arthritis (Murayama et al, 1992).
The possibility that AA was caused by CMV has recently been
suggested by Skinner et al (1995). They detected CMV DNA
sequences using polymerase chain reaction (PCR) in scalp biopsies
of AA. In nine paraffin-block sections of lesions of 10 cases, results
were positive for CMV. No CMV was found in nine of nine
patients with other types of alopecia. Skinner et al concluded that
these results should be considered as one possible factor in the
etiology of AA. The study by Grimes et al (1996) supported the
aboved-mentioned hypothesis. They detected CMV genome in
paraffin-embedded skin biopsies in 11 of 29 patients with vitiligo,
whereas CMV was absent in control subjects.
But the hypothesis that AA may be triggered by a CMV infection
was not confirmed by an in situ hybridization study carried out by
Tosti et al (1996). They analyzed 14 specimens from AA scalp
biopsies embedded in paraffin in parallel with positive controls for
each tissue sample.
We used three different PCR assays to detect CMV DNA in
skin punch biopsies obtained from three different groups of patients.
The first group consisted of 40 patients diagnosed as having AA as
first clinical episode of the disease or as recurrence cases. The
second group was three HIV infected patients with AA, and the
third group consisted of 12 other types of alopecia, androgenetic,
or cicatricial. The specimens were minced, and DNA for PCR was
obtained after proteolytic digestion and phenol/ethanol precipitation
(Aznar et al, 1993). Enzymatic amplification of 0.2–1 µg of DNA
of the infectious agent was performed with three different specific
CMV DNA amplification primers: (i) two primer sets directed
against the CMV immediate-early (IE) and late region followed by
hybridization with digoxigenin labeled probes (Shibata et al, 1988);
(ii) a nested multiplex PCR (REALR) (Tenorio et al, 1993); and
(iii) one primer set, directed against the CMV immediate-early
region (IE1) followed by hybridization with biotinylated probe
(GEN-ETI-KTM). CMV infected and noninfected human fibroblasts
were used as appropriate positive and negative controls, respectively.
The amplification products from 1 pfu could be detected in the
first PCR (Shibata et al, 1988), and the nested PCR protocol
allowed the detection of six genome equivalents of target DNA
(Olive et al, 1989). In addition, a primer set specific for human
betahemoglobin (KM38-GH20) was included as a control for
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successful extraction of DNA. No CMV DNA amplification was
found in the samples tested with the three assays.
The PCR technique has a higher sensitivity for the detection of
viral genomes in tissue samples than in situ hybridization, and it
has a lower rate of false-negative or false-positive results. The PCR
assays that we performed had a lower limit of detection of six gene
copies, which indicates that it is by far the most sensitive assay for
the detection of human CMV (Shibata et al, 1988; Hsia et al, 1989;
Olive et al, 1989). In addition, by using three assays that amplify
different genomic regions and incorporate different detection systems,
maximal sensitivity for the human CMV detection is achieved. We
believe that the data presented in this report do not support the
potential contribution of CMV in the pathogenesis of AA. Our
findings seem to contradict those of Skinner et al (1995), who used
the same set of primers and probes as those used in one of our
PCR. Tosti et al (1996) already suggested the lack of relationship
between CMV and AA. They used a less sensitive methodology
(i.e., in situ hybridization) than the one we report here, however.
PCR-based assays are by far the most sensitive method currently
available, although precautions have to be adopted to avoid
contaminations that may lead to false-positive results.
The controversy is not fully resolved, however, because Grimes
et al (1996) identified CMV DNA in patients with vitiligo, a disease
frequently associated with patients or relatives of patients with AA.
In our study, one patient also had vitiligo and eight had familiar
backgrounds of vitiligo without showing CMV DNA. Nevertheless,
we are currently performing another CMV DNA identification with
a large sample size of patients with vitiligo.
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